Umlobi: Joan Hall
Usuku Lokudalwa: 25 Ufebhuwari 2021
Ukuvuselela Usuku: 24 Ujuni 2024
Anonim
Витамин В2 (рибофлавин)
Ividiyo: Витамин В2 (рибофлавин)

-Delile

URiboflavin uyi-vitamin B. Kubandakanyeka ezinhlelweni eziningi emzimbeni futhi kuyadingeka ekukhuleni nasekusebenzeni okujwayelekile kweseli. Ingatholakala kokudla okuthile njengobisi, inyama, amaqanda, amantongomane, ufulawa ocebile nemifino eluhlaza. I-Riboflavin isetshenziswa kaningi ngokuhlanganiswa namanye amavithamini B kwimikhiqizo eyinkimbinkimbi ka-vitamin B.

Abanye abantu bathatha i-riboflavin ngomlomo ukuvikela amazinga aphansi e-riboflavin (ukuntuleka kwe-riboflavin) emzimbeni, ezinhlotsheni ezahlukahlukene zomdlavuza, kanye nasekhanda le-migraine. Iphinde ithathwe ngomlomo ngenxa yezinduna, amajaqamba emisipha, i-burning foot syndrome, i-carpal tunnel syndrome, nokuphazamiseka kwegazi okufana ne-congenital methemoglobinemia kanye ne-red cell aplasia. Abanye abantu basebenzisa i-riboflavin ngezimo zamehlo kufaka phakathi ukukhathala kweso, i-cataract, ne-glaucoma.

Abanye abantu futhi bathatha i-riboflavin ngomlomo ukuze balondoloze izinwele ezinempilo, isikhumba, nezinzipho, ukubamba ukuguga, ngenxa yezilonda zomdlavuza, i-multiple sclerosis, ukulahleka kwememori okubandakanya isifo i-Alzheimer's, umfutho wegazi ophakeme, ukusha, isifo sesibindi, ne-sickle cell anemia.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze RIBOFLAVIN zimi kanje:


Iyasebenza ku ...

  • Ukuvimbela nokwelapha amazinga aphansi e-riboflavin (ukuntuleka kwe-riboflavin). Kubantu abadala nezingane ezine-riboflavin encane kakhulu emzimbeni wabo, ukuthatha i-riboflavin ngomlomo kungakhuphula amazinga e-riboflavin emzimbeni.

Kungenzeka kusebenze ...

  • Isifo senkwethuAbantu abadla i-riboflavin eningi njengengxenye yokudla kwabo babonakala benengozi encane yokuhlaselwa ngulwelwesi. Futhi, ukuthatha izithasiselo eziqukethe i-riboflavin kanye ne-niacin kubonakala kusiza ukuvimbela i-cataract.
  • Inani eliphezulu le-homocysteine ​​egazini (hyperhomocysteinemia). Ukuthatha i-riboflavin ngomlomo amasonto ayi-12 kunciphisa amazinga e-homocysteine ​​aze afike kuma-40% kwabanye abantu. Futhi, ukuthatha i-riboflavin kanye ne-folic acid ne-pyridoxine kubonakala kwehlisa amazinga e-homocysteine ​​ngama-26% kubantu abanamazinga aphezulu we-homocysteine ​​abangelwa yimithi esetshenziselwa ukuvimbela ukuquleka.
  • Migraine ikhanda. Ukuthatha i-high-dose riboflavin ngomlomo kubonakala kunciphisa inani lokuhlaselwa kwekhanda le-migraine, ngokuhlaselwa okungaba ngu-2 ngenyanga. Ukuthatha i-riboflavin kuhlangene namanye amaminerali esihlabathi samavithamini kubonakala futhi ukuthi kunciphisa inani lobuhlungu obutholwa ngesikhathi se-migraine.

Kungenzeka kungasebenzi ku ...

  • Umdlavuza wesisu. Ukuthatha i-riboflavin kanye ne-niacin kuyasiza ekuvimbeleni umdlavuza wesisu.
  • Ukungondleki okubangelwa amaprotheni amancane ekudleni (kwashiorkor). Olunye ucwaningo luveza ukuthi ukuthatha i-riboflavin, i-vitamin E, i-selenium, ne-N-acetyl cysteine ​​ngomlomo akwehlisi uketshezi, kwenyuse ukuphakama noma isisindo, noma kwehlise ukutheleleka ezinganeni ezisengozini ye-kwashiorkor.
  • Umdlavuza wamaphaphu. Ukuthatha i-riboflavin ngomlomo kanye ne-niacin akusizi ukuvimbela umdlavuza wamaphaphu.
  • Umalaleveva. Ukuthatha i-riboflavin kanye ne-iron, i-thiamine, ne-vitamin C ngomlomo, akulinciphisi inani noma ubucayi bokutheleleka kukamalaleveva ezinganeni ezisengozini yokuvezwa umalaleveva.
  • Umfutho wegazi ophakeme ngesikhathi sokukhulelwa (pre-eclampsia). Kwabesifazane abanezinyanga ezine bekhulelwe, ukuqala ukuthatha i-riboflavin ngomlomo kunciphisa ubungozi be-pre-eclampsia ngesikhathi sokukhulelwa.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • I-Lactic acidosis (ukungalingani okungathi sína kwegazi ne-asidi) kubantu abane-immunodeficiency syndrome (i-AIDS). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-riboflavin ngomlomo kungasiza ekwelapheni i-lactic acidosis ebangelwa yimithi ebizwa nge-nucleoside analog reverse transcriptase inhibitors (NRTIs) ezigulini ezine-immunodeficiency syndrome (i-AIDS).
  • Umdlavuza wesibeletho. Ukwanda kokudla kwe-riboflavin kusuka emithonjeni yokudla neyokwengeza, kanye ne-thiamine, i-folic acid, ne-vitamin B12, kunganciphisa ubungozi bokuba nomdlavuza womlomo wesibeletho.
  • Umdlavuza wepayipi lokudla (umdlavuza we-esophageal). Ukucwaninga ngemiphumela ye-riboflavin yokuvimbela umdlavuza we-esophageal kuyaphikisana. Olunye ucwaningo lubonisa ukuthi ukuthatha i-riboflavin ngomlomo kunganciphisa ubungozi bokuthola umdlavuza wokuqopha, kanti olunye ucwaningo lukhombisa ukuthi alunamphumela.
  • Umfutho wegazi ophezulu. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-riboflavin ngomlomo ezigulini ezithile ezisengozini enkulu yomfutho wegazi ophakeme ngenxa yokwehluka kofuzo kunganciphisa ukucindezelwa kwegazi lapho kusetshenziswa ngaphezu kwemithi ebhalwe egazini.
  • Umdlavuza wesibindi. Ucwaningo lokuqala lukhombisa ukuthi ukuthatha i-riboflavin ne-niacin ngomlomo kunganciphisa ingozi yomdlavuza wesibindi kubantu abangaphansi kweminyaka engama-55 ubudala. Kodwa-ke, kubonakala sengathi yehlisa ubungozi bomdlavuza wesibindi kubantu asebekhulile.
  • I-Multiple sclerosis. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-riboflavin ngomlomo izinyanga eziyi-6 akukuthuthukisi ukukhubazeka ezigulini ezine-multiple sclerosis.
  • Amabala amhlophe ngaphakathi komlomo (leukoplakia yomlomo). Ucwaningo lwakuqala lukhombisa ukuthi amazinga aphansi e-riboflavin egazini axhumene nengozi eyengeziwe ye-leukoplakia yomlomo. Kodwa-ke, ukuthatha izithako ze-riboflavin ngomlomo izinyanga ezingama-20 akubonakali kuvimbela noma kwelapha i-leukoplakia yomlomo.
  • Ukushoda kwe-Iron ngesikhathi sokukhulelwa. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-riboflavin, i-iron, ne-folic acid ngomlomo akukhuphuli amazinga ensimbi kwabesifazane abakhulelwe ngaphezu kokuthatha nje i-iron ne-folic acid.
  • Isifo se-Sickle cell. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-riboflavin ngomlomo amasonto ayi-8 kwandisa amazinga ensimbi kubantu abanamazinga aphansi ensimbi ngenxa yesifo se-sickle cell.
  • Unhlangothi. Ucwaningo lokuqala lukhombisa ukuthi ukuthatha i-riboflavin ne-niacin ngomlomo akuvimbeli ukufa okuhlobene nohlangothi kubantu abasengozini yokushaywa unhlangothi.
  • Izinduna.
  • Ukuguga.
  • Ukuqinisa amasosha omzimba.
  • Izilonda zekhankatha.
  • Ukugcina isikhumba nezinwele ziphilile.
  • Ukulahleka kwememori kufaka phakathi isifo i-Alzheimer's.
  • Amajaqamba emisipha.
  • Ezinye izimo.
Kudingeka ubufakazi obengeziwe ukukala ukusebenza kwe-riboflavin kulokhu kusetshenziswa.

I-Riboflavin iyadingeka ekukhuleni okufanele kwezinto eziningi emzimbeni kubandakanya isikhumba, ulwelwesi lwendlela yokugaya ukudla, amaseli egazi, nokusebenza kwengqondo.

URiboflavin unjalo CISHE UVIKILE kubantu abaningi lapho bethathwa ngomlomo. Kwabanye abantu, i-riboflavin ingadala ukuthi umchamo uguqule umbala ophuzi-olintshi. Kungadala nohudo.

Ukuqapha okukhethekile nezixwayiso:

Izingane: URiboflavin unjalo CISHE UVIKILE ezinganeni eziningi lapho zithathwa ngomlomo ngamanani afanele njengoba kunconyiwe yiBhodi Yezokudla Nezokudla yeNational Institute of Medicine (bheka isigaba sokulinganisa ngezansi).

Ukukhulelwa nokuncelisa ibele: URiboflavin unjalo CISHE UVIKILE lapho ithathwa ngomlomo futhi isetshenziswe ngokufanele kwabesifazane abakhulelwe noma abancelisa ibele. Inani elinconyiwe lingu-1.4 mg ngosuku kwabesifazane abakhulelwe kanye no-1.6 mg ngosuku kwabesifazane abancelisa ibele. URiboflavin unjalo OKUNGENZEKA UKUPHEPHA lapho ithathwa ngomlomo ngemithamo emikhulu, isikhathi esifushane. Olunye ucwaningo lukhombisa ukuthi i-riboflavin iphephile lapho ithathwa ngomthamo we-15 mg kanye njalo emavikini amabili amasonto ayi-10.

I-Hepatitis, i-Cirrhosis, ukuvinjelwa kwe-BillaryUkufakwa kwe-Riboflavin kunciphile kubantu abanale mibandela.

Maphakathi
Qaphela ngale nhlanganisela.
Ama-antibiotic (ama-antibiotic eTetracycline)
I-Riboflavin inganciphisa inani lama-tetracyclines umzimba ongawamunca. Ukuthatha i-riboflavin kanye ne-tetracyclines kunganciphisa ukusebenza kwe-tetracyclines. Ukugwema lokhu kuhlangana, thatha i-riboflavin amahora amabili ngaphambi noma amahora amane ngemuva kokuthatha i-tetracyclines.

Amanye ama-tetracyclines afaka phakathi i-demeclocycline (i-Declomycin), i-minocycline (i-Minocin), ne-tetracycline (i-Achromycin).
Okuncane
Qaphela ngale nhlanganisela.
Ukomisa imithi (Izidakamizwa ze-Anticholinergic)
Eminye imishanguzo yokumisa ingathinta isisu namathumbu. Ukuthatha le mithi yokumisa nge-riboflavin (i-vitamin B2) kungakhuphula inani le-riboflavin eligxile emzimbeni. Kepha akwaziwa ukuthi lokhu kusebenzisana kubalulekile.
Eminye yale mithi yokumisa ihlanganisa i-atropine, i-scopolamine, kanye neminye imithi esetshenziselwa ukwaliwa (ama-antihistamines), kanye nokudangala (ama-anti-depressants).
Imithi yokudangala (iTricyclic antidepressants)
Eminye imishanguzo yokudangala inganciphisa inani le-riboflavin emzimbeni. Lokhu kuxhumana akuyona inkinga enkulu ngoba kwenzeka kuphela ngamanani amakhulu kakhulu emithi ethile yokudangala. Eminye imithi esetshenziselwa ukucindezeleka ifaka i-amitriptyline (Elavil) noma i-imipramine (iTofranil, uJanimine), neminye.
I-Phenobarbital (Luminal)
I-Riboflavin idilizwe ngumzimba. I-Phenobarbital ingakhuphula ukuthi i-riboflavin isheshe yehle kanjani emzimbeni. Akucaci ukuthi lokhu kusebenzisana kubalulekile.
I-Probenecid (Benemid)
I-Probenecid (i-Benemid) ingakhuphula inani le-riboflavin esemzimbeni. Lokhu kungadala ukuthi kube ne-riboflavin eningi kakhulu emzimbeni. Kepha akwaziwa ukuthi lokhu kusebenzisana kuyinkinga enkulu yini.
I-psyllium emhlophe
I-Psyllium inciphisa ukumuncwa kwe-riboflavin kusuka kwizithasiselo kwabesifazane abaphilile. Akucaci noma lokhu kwenzeka nge-riboflavin yokudla, noma ngabe kubaluleke kakhulu empilweni.
IBoron
Uhlobo lwe-boron, olubizwa nge-boric acid, lunganciphisa ukuncibilika kwe-riboflavin emanzini. Lokhu kunganciphisa ukumuncwa kwe-riboflavin.
I-folic acid
Kubantu abanesimo esibizwa ngokuthi yi-methylenetetrahydrofolate reductase (MTHFR), ukuthatha i-folic acid kungenza ukuntuleka kwe-riboflavin kube kubi kakhulu. I-Folic acid ingehlisa amazinga egazi e-riboflavin kubantu abanalesi simo.
Insimbi
Izithako ze-Riboflavin zingathuthukisa indlela izengezo zensimbi ezisebenza ngayo kwabanye abantu abangenayo i-ayoni eyanele. Lo mphumela mhlawumbe ubalulekile kuphela kubantu abanesifo se-riboflavin.
Ukudla
Ukuncipha kwezithako ze-riboflavin kungakhuphuka lapho kuthathwa nokudla.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA

NGOMLOMO:
  • Jikelele: Isibonelelo sokudla esinconyiwe (i-RDA) se-riboflavin sabantu abadala singu-1.3 mg ngosuku kwabesilisa, u-1.1 mg ngosuku kwabesifazane, u-1.4 mg ngosuku wabesifazane abakhulelwe, no-1.6 mg ngosuku wabesifazane abancelisayo. Awekho amazinga we-Upper Intake Levels (UL) ansuku zonke e-riboflavin, okuyizinga eliphakeme kakhulu lokudla okungenzeka ukuthi kungabi nengozi yemiphumela emibi.
  • Ngokuvikela nokwelapha amazinga aphansi e-riboflavin (ukuntuleka kwe-riboflavin)Kusetshenziswe i-Riboflavin 5-30 mg nsuku zonke.
  • NgamehloKusetshenziswe inhlanganisela ye-riboflavin 3 mg kanye ne-niacin 40 mg nsuku zonke iminyaka engu-5-6.
  • Ngamazinga aphezulu we-homocysteine ​​egazini)Kusetshenziswe i-Riboflavin 1.6 mg nsuku zonke amasonto ayi-12. Inhlanganisela equkethe i-75 mg ye-riboflavin, i-0.4 mg ye-folic acid, ne-120 mg ye-pyridoxine nsuku zonke izinsuku ezingama-30 nayo isetshenzisiwe.
  • Ngezinkinga zekhanda ze-migraine: Umthamo ovame kakhulu yi-riboflavin 400 mg nsuku zonke okungenani izinyanga ezintathu. Kusetshenziswe umkhiqizo othile (iDolovent; Linpharma Inc., Oldsmar, FL) ngamaphilisi amabili ekuseni namaphilisi amabili kusihlwa izinyanga ezintathu. Lo mthamo unikeza inani eliphelele le-riboflavin 400 mg, i-magnesium 600 mg, ne-coenzyme Q10 150 mg ngosuku.
IZINGANE

NGOMLOMO:
  • Jikelele: Isibonelelo sokudla esinconyiwe (i-RDA) se-riboflavin singu-0.3 mg ngosuku wezinsana kuze kufike ezinyangeni eziyisithupha ubudala, u-0.4 mg ngosuku wezinsana ezinezinyanga eziyisithupha kuya kwezi-12 ubudala, u-0.5 mg ngosuku wezingane ezineminyaka engu-1-3 ubudala, u-0.6 mg usuku lwezingane ezineminyaka engu-4-8 ubudala, u-0.9 mg ngosuku wezingane ezineminyaka engu-9-13 ubudala, u-1.3 mg ngosuku kwabesilisa abaneminyaka engu-14-18 ubudala, no-1.0 mg ngosuku kwabesifazane abayi-14-18. Awekho amazinga we-Upper Intake Levels (UL) ansuku zonke e-riboflavin, okuyizinga eliphakeme kakhulu lokudla okungenzeka ukuthi kungabi nengozi yemiphumela emibi.
  • Ngokuvikela nokwelapha amazinga aphansi e-riboflavin (ukuntuleka kwe-riboflavin): I-Riboflavin 2 mg kanye, bese kusetshenziswa u-0.5-1.5 mg nsuku zonke izinsuku eziyi-14. I-Riboflavin 2-5 mg nsuku zonke kuze kube izinyanga ezimbili isetshenzisiwe. I-Riboflavin 5 mg izinsuku ezinhlanu ngesonto kuze kube unyaka owodwa nayo isetshenzisiwe.
B Complex Vitamin, Complexe de Vitamines B, Flavin, Flavine, Lactoflavin, Lactoflavine, Riboflavin 5 ’Phosphate, Riboflavin Tetrabutyrate, Riboflavina, Riboflavine, Vitamin B2, Vitamin G, Vitamina B2, Vitamine B2, Vitamine G.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. Ukufakwa kwereferensi yokudla (ama-DRIs): izidingo ezilinganisiwe ezijwayelekile. Ibhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha, Izifundo Zikazwelonke. https://www.nal.usda.gov/sites/default/files/fnic_uploads//recommended_intakes_individuals.pdf Kufinyelelwe ngoJulayi 24, 2017.
  2. UWilson CP, McNulty H, Ward M, et al. Umfutho wegazi kubantu abaphethwe umfutho wegazi ophakeme abane-MTHFR 677TT genotype iyaphendula ekungeneleni nge-riboflavin: ukutholwa kwesilingo esihlosiwe esihlosiwe. Umfutho wegazi ophezulu. 2013; 61: 1302-8. Buka okungaqondakali.
  3. UWilson CP, uWard M, uMcNulty H, et al. URiboflavin unikeza isu elihlosiwe lokulawula umfutho wegazi ophezulu ezigulini ezine-genotype ye-MTHFR 677TT: ukulandelwa kwe-4-y. Ngingu-J J Nutriti Womtholampilo. 2012; 95: 766-72. Buka okungaqondakali.
  4. UGaul C, uDiener HC, uDanesch U; Iqembu leMigravent Study. Ukwenza ngcono izimpawu ze-migraine ngesengezo sebhizinisi esiqukethe i-riboflavin, i-magnesium ne-Q10: isilingo esingahleliwe, esilawulwa nge-placebo, esiyimpumputhe kabili, esinamacala amaningi. J ikhanda nobuhlungu. 2015; 16: 516. Buka okungaqondakali.
  5. UNaghashpour M, Majdinasab N, uShakakerinejad G, et al. Ukuxhaswa kweRiboflavin ezigulini ezine-multiple sclerosis akusithuthukisi isimo sokukhubazeka futhi i-riboflavin supplementation ayihambelani ne-homocysteine. I-Int J Vitam Nutr Res. 2013; 83: 281-90. Buka okungaqondakali.
  6. I-Lakshmi, A. V. Riboflavin metabolism - ukuhambisana nokudla komuntu. AmaNdiya J Med Res 1998; 108: 182-190. Buka okungaqondakali.
  7. UPascale, J. A., Mims, L. C., Greenberg, M.H, Gooden, D. S., noChronister, E. Riboflaven nempendulo ye-bilirubin ngesikhathi se-phototherapy. I-Pediatr. I-1976; 10: 854-856. Buka okungaqondakali.
  8. UMadigan, SM, Tracey, F., McNulty, H., Eaton-Evans, J., Coulter, J., McCartney, H., no-Strain, uJJ Riboflavin kanye nokufakwa kukavithamini B-6 nesimo kanye nokuphendula kwamakhemikhali ekwenziweni kwe-riboflavin kubantu abadala abaphila ngokukhululeka. Ngingu-J J Clin Nutr 1998; 68: 389-395. Buka okungaqondakali.
  9. USammon, A. M. no-Alderson, D. Ukudla, i-reflux kanye nokuthuthukiswa kwe-squamous cell carcinoma ye-esophagus e-Afrika. Br J Ukuhlinzwa. 1998; 85: 891-896. Buka okungaqondakali.
  10. UMatimoe, D. noNewton, W. I-high-dose riboflavin ye-migraine prophylaxis. J Fam Khipha. 1998; 47: 11. Buka okungaqondakali.
  11. USolomons, N. W. Micronutrients kanye nendlela yokuphila yasemadolobheni: izifundo ezivela eGuatemala. I-Arch. I-Latinoam. Nutrut 1997; 47 (2 Suppl 1): 44-49. Buka okungaqondakali.
  12. UWadhwa, A., Sabharwal, M., noSharma, S. Isimo sezempilo sabantu abadala. I-Indian J Med Res 1997; 106: 340-348. Buka okungaqondakali.
  13. ISpirichev, VB, Kodentsova, VM, Isaeva, VA, Vrzhesinskaia, OA, Sokol'nikov, AA, Blazhevvich, NV, neBeketova, NA [Isimo se-Vitamin sabantu abavela ezifundeni ezihlaselwe yingozi eChernobyl, kanye ukulungiswa ngama-multivitamin "Duovit" kanye "Undevit" kanye ne-multivitamin premix 730/4 yenkampani "Roche"]. I-Vopr. IPitan. 1997;: 11-16. Buka okungaqondakali.
  14. D'Avanzo, B., Ron, E., La, Vecchia C., Francaschi, S., Negri, E., noZleglar, R. Kukhethwe ingozi yokudla okune-micronutrient kanye ne-thyroid carcinoma. Umdlavuza 6-1-1997; 79: 2186-2192. Buka okungaqondakali.
  15. I-Kodentsova, i-VM, i-Pustograev, i-NN, i-Vrzhesinskaia, i-OA, i-Kharitonchik, i-LA, i-Pereverzeva, i-OG, i-Iakushina, i-LM, i-Trofimenko, i-LS, ne-Spirichev, i-VB [Ukuqhathaniswa kwe-metabolism yamavithamini ancibilika emanzini ezinganeni ezinempilo nasezinganeni ezine-insulin- isifo sikashukela esincike kuye ngokuya ngezinga lamavithamini ekudleni]. I-Vopr.Med Khim. 1996; 42: 153-158. Buka okungaqondakali.
  16. UWynn, M. noWynn, A. Ngabe ukudla okuthuthukisiwe kungasiza ekuvimbeleni i-cataract? Impilo Yezempilo 1996; 11: 87-104. Buka okungaqondakali.
  17. Ito, K. noKawanishi, S. [Ukulimala kwe-DNA okwenziwe nge-Photosensitized: izindlela nokusetshenziswa kwemitholampilo]. UNihon Rinsho 1996; 54: 3131-3142. Buka okungaqondakali.
  18. UPorcelli, P. J., Adcock, E. W., DelPaggio, D., Swift, L. L., noGreene, H. L. Plasma kanye nomchamo i-riboflavin kanye ne-pyridoxine ukugxila kokudla okunesisindo esiphansi kakhulu. UJ Pediatr. I-Gastroenterol. I-Nutr 1996; 23: 141-146. Buka okungaqondakali.
  19. UZempleni, J., Galloway, J. R., noMcCormick, D. B. Ukukhonjwa kanye ne-kinetics ye-7 alpha-hydroxyriboflavin (7-hydroxymethylriboflavin) ku-plasma yegazi evela kubantu kulandela ukulawulwa ngomlomo izithako ze-riboflavin. I-Int J Vitam. I-Nutr Res 1996; 66: 151-157. Buka okungaqondakali.
  20. Williams, P. G. Ukugcinwa kwamavithamini ekuphekeni / ekupholiseni nasekuphekeni / ezinsizeni ezishisayo zokuhlinzeka ngokudla esibhedlela. J Am Ukudla. 1996; 96: 490-498. Buka okungaqondakali.
  21. UZempleni, J., Galloway, J. R., noMcCormick, D. B. Pharmacokinetics ye-riboflavin elawulwa ngomlomo nangomjovo kubantu abanempilo. NginguJ J Nutriti 1996; 63: 54-66. Buka okungaqondakali.
  22. URosado, J. L., Bourges, H., noSaint-Martin, B. [Ukuntuleka kwamavithamini namaminerali eMexico. Ukubuyekezwa okubucayi kwesimo sobuciko. II. Ukushoda ngamavithamini]. USalud Publica Mex. 1995; 37: 452-461. Buka okungaqondakali.
  23. Amandla, H. J. Riboflavin-iron ukuxhumana ngokugxila ikakhulukazi kumgudu wamathumbu. I-Proc. Nutr Soc 1995; 54: 509-517. Buka okungaqondakali.
  24. UHeseker, H. noKubler, W.Ukukhula okungapheli kwamavithamini kanye nesimo sevithamini samadoda aphilile. Ukudla okunomsoco 1993; 9: 10-17. Buka okungaqondakali.
  25. Igbedioh, S. O. Ukungondleki kahle eNigeria: ubukhulu, izimbangela namakhambi okuphungula endaweni eguqukayo yezenhlalo nezomnotho. Impilo Yezempilo 1993; 9: 1-14. Buka okungaqondakali.
  26. U-Ajayi, O. A., George, B. O., no-Ipadeola, T. Isivivinyo somtholampilo se-riboflavin esifo se-sickle cell. EMpumalanga Afr. UMed J 1993; 70: 418-421. Buka okungaqondakali.
  27. UZaridze, D., Evstifeeva, T., noBoyle, P. Chemoprevention we-leukoplakia yomlomo kanye ne-esophagitis engapheli endaweni enezifo eziphezulu zomdlavuza womlomo nowomlomo. U-Ann Epidemiol 1993; 3: 225-234. Buka okungaqondakali.
  28. Chen, R. D. [Chemoprevention of cancer cancer - study intervention of cervical precancerous lesions by retinamide II kanye riboflavin]. UZhonghua Zhong. Liu Za Zhi 1993; 15: 272-274. Buka okungaqondakali.
  29. Bates, C. J., Prentice, A. M., noPaul, A. A. Ukwehluka kwesizini kwamavithamini A, C, riboflavin kanye nokutholwa kwama-folate kanye nesimo sabesifazane abakhulelwe nabancelisayo emphakathini wasemaphandleni waseGambia: eminye imiphumela. I-Eur. J Clin Nutriti 1994; 48: 660-668. Buka okungaqondakali.
  30. van der Beek, E. J., van, Dokkum W., Wedel, M., Schrijver, J., noVan den Berg, H. Thiamin, riboflavin novithamini B6: umthelela wokudla okuvinjelwe ekusebenzeni komzimba kumuntu. UJ Am Coll Nutriti 1994; 13: 629-640. Buka okungaqondakali.
  31. UTrygg, K., Lund-Larsen, K., Sandstad, B., Hoffman, H. J., Jacobsen, G., noBakketeig, L. S. Ngabe ababhemayo abakhulelwe badla ngokwehlukile kwabakhulelwe abangabhemi? I-Paediatr. I-Perinat. I-Epidemiol 1995; 9: 307-319. Buka okungaqondakali.
  32. I-Benton, D., i-Haller, i-J, ne-Fordy, i-J. I-Neuropsychobiology 1995; 32: 98-105. Buka okungaqondakali.
  33. Schindel, L. Inkinga ye-placebo. I-Eur.J Clin Pharmacol 5-31-1978; 13: 231-235. Buka okungaqondakali.
  34. UCherstvova, L. G. [Indima yebhayoloji kavithamini B2 ekushodeni kwe-iron anemia]. IGematol.Transfuziol. 1984; 29: 47-50. Buka okungaqondakali.
  35. Bates, C. J., Flewitt, A., Prentice, A. M., Lamb, W. H., noWhitehead, R. G. Ukusebenza kwesengezo se-riboflavin esinikezwa ngezikhathi zobusuku obubodwa kwabesifazane abakhulelwe nabancelisayo emaphandleni aseGambia. Umsoco weNutr Clin Nutr 1983; 37: 427-432. Buka okungaqondakali.
  36. I-Bamji, M. S. Ukushoda kwamavithamini kubantu abadla ilayisi. Imiphumela yezithasiselo ze-B-vithamini. I-Experientia Suppl 1983; 44: 245-263. Buka okungaqondakali.
  37. UBamji, M. S., Sarma, K. V., noRadhaiah, G. Ubudlelwano phakathi kwezimpawu zamakhemikhali nezemitholampilo zokushoda kwe-B-vitamin. Ucwaningo kubafana besikole sasemakhaya. UBr J Nutr 1979; 41: 431-441. Buka okungaqondakali.
  38. UHovi, L., Hekali, R., noSiimes, M. A. Ubufakazi bokuncipha kwe-riboflavin ezinganeni ezisancela ebeleni kanye nokusheshisa kwayo okuqhubekayo ngesikhathi sokwelashwa kwe-hyperbilirubinemia nge-phototherapy. I-Acta Paediatr.Skand. 1979; 68: 567-570. Buka okungaqondakali.
  39. Bheka, C. S. Riboflavin isimo sentsha yamaShayina aseningizimu: izifundo zokugcwalisa i-riboflavin. Umsoco weNutr Clin Nutr 1985; 39: 297-301. Buka okungaqondakali.
  40. URudolph, N., Parekh, A. J., Hittelman, J., Burdige, J., noWong, S. L. Ukwehla kokubeletha kwe-pyridoxal phosphate ne-riboflavin. Ukuqhakambisa nge-phototherapy. Ngingu-J Dis Child 1985; 139: 812-815. Buka okungaqondakali.
  41. Holmlund, D. noSjodin, J. G. Ukwelashwa kwe-ureteral colic nge-intravenous indomethacin. J Urol. 1978; 120: 676-677. Buka okungaqondakali.
  42. Amandla, H. J., Bates, C. J., Eccles, M., Brown, H., noGeorge, E. Ukusebenza kwamabhayisikili ezinganeni zaseGambia: imiphumela yezithasiselo ze-riboflavin noma i-ascorbic acid. Umsoco weNutr Clin Nutrition 1987; 41: 59-69. Buka okungaqondakali.
  43. UPinto, J. T. noRivlin, R. S. Izidakamizwa ezikhuthaza ukukhishwa kwezinso kwe-riboflavin. Ukusebenzisana Kwezidakamizwa. 1987; 5: 143-151. Buka okungaqondakali.
  44. UWahrendorf, J., Munoz, N., Lu, JB, Thurnham, DI, Crespi, M., noBosch, iFX Blood, i-retinol kanye ne-zinc riboflavin isimo maqondana nezilonda ezingaphambi kwesikhala somzimba: okutholakele esivivinyweni sokungenelela kwamavithamini i-People's Republic of China. ICancer Res 4-15-1988; 48: 2280-2283. Buka okungaqondakali.
  45. Lin, P. Z., Zhang, J. S., Cao, S. G., Rong, Z. P., Gao, R. Q., Han, R., noShu, S. P. [Ukuvimbela okwesibili umdlavuza we-esophageal - ukungenelela kwezilonda ezingaphambi kwesisu). UZhonghua Zhong. Liu Za Zhi 1988; 10: 161-166. Buka okungaqondakali.
  46. van der Beek, EJ, van, Dokkum W., Schrijver, J., Wedel, M., Gaillard, AW, Wesstra, A., van de Weerd, H., noHermus, RJ Thiamin, riboflavin, namavithamini B- I-6 ne-C: umthelela wokudla okunomkhawulo okuhlanganisiwe ekusebenzeni kokusebenza kumuntu. Ngingu-J J Nutriti 1988; 48: 1451-1462. Buka okungaqondakali.
  47. UZaridze, D. G., Kuvshinov, J. P., Matiakin, E., Polakov, B. I., Boyle, P., noBlettner, M. Chemoprevention womdlavuza womlomo nowokuqumba e-Uzbekistan, Union of Soviet Socialist Republics. Natl.Cancer Inst.Monogr 1985; 69: 259-262. Buka okungaqondakali.
  48. UMunoz, N., Wahrendorf, J., Bang, L. J., Crespi, M., Thurnham, D. I., Day, N. E., Ji, Z. H., Grassi, A., Yan, L. W., Lin, L. G., kanye no. Awukho umthelela we-riboflavine, i-retinol, ne-zinc ekusakazekeni kwezilonda ezingaphambi kokuqina zomphimbo. Ucwaningo lokungenelela olwenziwe izimpumputhe olungahleliwe kubantu abasengozini enkulu yaseChina. ILancet 7-20-1985; 2: 111-114. Buka okungaqondakali.
  49. U-Wang, Z. Y. [Chemoprevention endaweni esezingeni eliphezulu yomdlavuza wamaphaphu]. UZhonghua Zhong. Liu Za Zhi 1989; 11: 207-210. Buka okungaqondakali.
  50. IHargreaves, M. K., Baquet, C., noGamshadzahi, A. Ukudla, isimo somsoco, kanye nomdlavuza engozini kwabamnyama baseMelika. I-Cancer Cancer 1989; 12: 1-28. Buka okungaqondakali.
  51. I-Desai, i-ID, i-Doell, i-AM, i-Officiati, i-SA, i-Bianco, i-AM, i-Van, i-Severen Y., i-Desai, i-MI, i-Jansen, i-E, ne-Oliveira, i-JE Ukuhlolwa kwezidingo zokudla okunempilo kwabafuduki basemaphandleni aseningizimu yeBrazil: ukuklama, ukusebenzisa kanye nokuhlola uhlelo lokufundisa ngokudla okunomsoco. Ukudla Kwezwe Umfu. 1990; 61: 64-131. Buka okungaqondakali.
  52. I-Suboticanec, K., Stavljenic, A., Schalch, W., neBuzina, R. Imiphumela ye-pyridoxine ne-riboflavin supplementation ekuqiniseni umzimba ezinganeni ezisencane. I-Int J Vitam. 1990; 60: 81-88. Buka okungaqondakali.
  53. UTurkki, P. R., Ingerman, L., Schroeder, L. A., Chung, R. S., Chen, M., Russo-McGraw, M. A., noDearlove, J. Riboflavin ukungena kanye nesimo sabantu besifazane abakhuluphele ngokweqile phakathi nonyaka wokuqala wokusebenza ngemuva kwesisu. UJ Am Coll Nutriti 1990; 9: 588-599. Buka okungaqondakali.
  54. IHoppel, uC. L. noTandler, B. Ukushoda kweRiboflavin. Inqubekela phambili. Clin Biol. 1990; 321: 233-248. Buka okungaqondakali.
  55. I-Lin, P. [Ukwelashwa ngemithi yokuvimbela okwenzakalayo kwezilonda zomphimbo - iminyaka emi-3 nengu-5 yokuvimbela umphumela we-antitumor B, i-retinamide ne-riboflavin]. UZhongguo Yi Xue Ke Xue Yuan Xue Bao 1990; 12: 235-245. Buka okungaqondakali.
  56. ULin, P., Zhang, J., Rong, Z., Han, R., Xu, S., Gao, R., Ding, Z., Wang, J., Feng, H., noCao, S. Izifundo zokwelashwa okuvimbela ukwelashwa kwezilonda ezingaphambi kokuphamba - iminyaka emi-3- kanye neminyaka emi-5 yokuvimbela imiphumela ye-antitumor-B, retinamide ne-riboflavin. I-Proc. Chin Acad Med Sci Peking. Inyunyana Med Coll 1990; 5: 121-129. Buka okungaqondakali.
  57. Odigwe, C. C., Smedslund, G., Ejemot-Nwadiaro, R. I., Anyanechi, C. C., noKrawinkel, M. B. Supplementary vitamin E, selenium, cysteine ​​kanye ne riboflavin yokuvikela i-kwashiorkor ezinganeni zasenkulisa emazweni asathuthuka. Idatha yedatha yeCochrane. 2010; CD008147. Buka okungaqondakali.
  58. I-Koller, T., i-Mrochen, i-M, ne-Seiler, i-T.Izinga lokuncintisana nokwehluleka ngemuva kokuxhumeka kwe-corneal. J Cataract Refract. Ukuhlinzwa. U-2009; 35: 1358-1362. Buka okungaqondakali.
  59. IMacLennan, S. C., Wade, F. M., Forrest, K. M., Ratanayake, P. D., Fagan, E., no-Antony, J. I-high-dose riboflavin ye-migraine prophylaxis ezinganeni: isilingo esilawulwa kabili, esingahleliwe, esilawulwa yi-placebo. J Ingane Neurol. 2008; 23: 1300-1304. Buka okungaqondakali.
  60. UWittig-Silva, C., Whiting, M., Lamoureux, E., Lindsay, R. G., Sullivan, L. J., noSnibson, G. R. Isivivinyo esilawulwa ngokungahleliwe sokuxhuma kwe-corneal collagen ku-keratoconus eqhubekayo: imiphumela yokuqala. J Refract. Ukuhlinzwa. 2008; 24: S720-S725. Buka okungaqondakali.
  61. U-Evers, S. [Ezinye izindlela zokuvimbela i-beta ekwelashweni kokuvikela i-migraine]. UNervenarzt 2008; 79: 1135-40, 1142. Buka okungaqondakali.
  62. Ma, AG, Schouten, EG, Zhang, FZ, Kok, FJ, Yang, F., Jiang, DC, Sun, YY, noHan, XX Retinol kanye ne-riboflavin supplementation kunciphisa ukwanda kwe-anemia kwabesifazane abakhulelwe baseChina abathatha i-iron ne-folic Izithako ze-acid. J Umuthi 2008; 138: 1946-1950. Buka okungaqondakali.
  63. U-Liu, G., Lu, C., Yao, S., Zhao, F., Li, Y., Meng, X., Gao, J., Cai, J., Zhang, L., no-Chen, Z. Indlela ye-Radiosensitization ye-riboflavin in vitro. ISci China C. Life Sci 2002; 45: 344-352. Buka okungaqondakali.
  64. I-Figueiredo, JC, Levine, AJ, Grau, MV, Midttun, O., Ueland, PM, Ahnen, DJ, Barry, EL, Tsang, S., Munroe, D., Ali, I., Haile, RW, Sandler, I-RS, ne-Baron, i-JA Vitamin B2, i-B6, ne-B12 kanye nobungozi bama-adenomas amasha amachashazi esivivinyweni esingahleliwe sokusetshenziswa kwe-aspirin kanye ne-folic acid supplementation. I-Cancer Epidemiol Biomarkers Prev 2008; 17: 2136-2145. Buka okungaqondakali.
  65. UMcNulty, H. noScott, J. M. Ukudla kanye nesimo sama-vithamini e-B e-folate futhi ahlobene: ukucatshangelwa nezinselelo ekufinyeleleni esimweni esihle. UBr J Nutr 2008; 99 Isalufu 3: S48-S54. Buka okungaqondakali.
  66. U-Premkumar, V. G., Yuvaraj, S., Shanthi, P., noSachdanandam, P. Co-enzyme Q10, riboflavin kanye ne-niacin supplementation ekuguqulweni kwe-enzyme yokulungisa i-DNA kanye ne-DNA methylation ezigulini zomdlavuza webele ezelashwa nge-tamoxifen therapy. UBr. J Nutriti 2008; 100: 1179-1182. Buka okungaqondakali.
  67. Sporl, E., Raiskup-Wolf, F., noPillunat, L. E. [Izimiso ze-Biophysical zokuxhuma kwe-collagen]. UKlin Monbl.Augenheilkd. 2008; 225: 131-137. Buka okungaqondakali.
  68. I-Lynch, S. Ithonya lokutheleleka / ukuvuvukala, i-thalassemia nesimo sokudla okunomsoco ekumungeni kwensimbi. I-Int J Vitam. I-Nutr Res 2007; 77: 217-223. Buka okungaqondakali.
  69. UFischer Walker, CL, Baqui, AH, Ahmed, S., Zaman, K., El, Arifeen S., Begum, N., Yunus, M., Black, RE, noCaulfield, LE Isilinganiso esiphansi samasonto onke sensimbi futhi / noma i-zinc ayikuthinti ukukhula phakathi kwezinsana zaseBangladeshi. I-Eur. J Clin Nutrition 2009; 63: 87-92. Buka okungaqondakali.
  70. UKoller, T. noSeiler, T. [Ukuxhumanisa okwelaphayo kwe-cornea usebenzisa i-riboflavin / UVA]. UKlin Monbl.Augenheilkd. 2007; 224: 700-706. Buka okungaqondakali.
  71. Ukushoda kwe-Riboflavin, i-galactose metabolism kanye ne-cataract. Umsoco Isambulo 1976; 34: 77-79. Buka okungaqondakali.
  72. I-Premkumar, VG, Yuvaraj, S., Vijayasarathy, K., Gangadaran, SG, neSachdanandam, P. Serum amazinga e-cytokine we-interleukin-1beta, -6, -8, tumor necrosis factor-alpha and vascular endothelial growth factor in cancer iziguli eziphathwe nge-tamoxifen futhi zengezwa nge-co-enzyme Q, i-riboflavin ne-niacin. I-Basic Clin Pharmacol Toxicol 2007; 100: 387-391. Buka okungaqondakali.
  73. I-Ito, K., Hiraku, Y., neKawanishi, S. Photosensitized DNA umonakalo obangelwe yi-NADH: ukucaciswa kwesayithi nemishini. I-Radic yamahhala. 2007; 41: 461-468. Buka okungaqondakali.
  74. USrihari, G., Eilander, A., Muthayya, S., Kurpad, A. V., noSeshadri, S. Isimo somsoco wezingane zesikole sase-India ezicebile: sazi ini futhi kangakanani? Indian Pediatr. 2007; 44: 204-213. Buka okungaqondakali.
  75. UGariballa, S. no-Ullegaddi, R. Isimo seRiboflavin kuhlangothi olubi lwe-ischemic. I-Eur. J Clin Nutriti 2007; 61: 1237-1240. Buka okungaqondakali.
  76. USingh, A., Moses, F. M., noDeuster, P. A. Vitamin nesimo samaminerali emadodeni asebenzayo: imiphumela yokwengeza amandla amakhulu. Ngingu-J Clin Nutrit 1992; 55: 1-7. Buka okungaqondakali.
  77. U-Premkumar, V. G., Yuvaraj, S., Vijayasarathy, K., Gangadaran, S. G., noSachdanandam, P. Umphumela we-coenzyme Q10, riboflavin kanye ne-niacin ku-serum CEA kanye namazinga e-CA 15-3 ezigulini zomdlavuza webele ezelashwa nge-tamoxifen therapy. IBiol Pharm Bull. 2007; 30: 367-370. Buka okungaqondakali.
  78. Stracciari, A., D'Alessandro, R., Baldin, E., noGuarino, M. Post-ukufakelwa ikhanda ikhanda: inzuzo kwi-riboflavin. Eur.Neurol. 2006; 56: 201-203. Buka okungaqondakali.
  79. I-Wollensak, G. Ukwelashwa kwe-keratoconus okuqhubekayo: ithemba elisha. I-Curr Opin Ophthalmol. 2006; 17: 356-360. Buka okungaqondakali.
  80. ICaporossi, A., Baiocchi, S., Mazzotta, C., Traversi, C., noCaporossi, T. Ukwelashwa ngeparasurgical keratoconus ngohlobo lwe-riboflavin-ultraviolet A imisebe ebangele ukuxhumanisa i-corneal collagen: imiphumela yokuqala yokuphamba e-Italy funda. J Cataract Refract. Ukuhlinzwa. 2006; 32: 837-845. Buka okungaqondakali.
  81. Bugiani, M., Lamantea, E., Invernizzi, F., Moroni, I., Bizzi, A., Zeviani, M., no-Uziel, G. Imiphumela ye-riboflavin ezinganeni ezinenkinga II eyinkimbinkimbi. I-Brain Dev 2006; 28: 576-581. Buka okungaqondakali.
  82. UNeugebauer, J., Zanre, Y., noWacker, J. Riboflavin ukwengeza kanye ne-preeclampsia. Int J Gynaecol.Obstet. 2006; 93: 136-137. Buka okungaqondakali.
  83. UMcNulty, H., Dowey le, RC, Strain, JJ, Dunne, A., Ward, M., Molloy, AM, McAnena, LB, Hughes, JP, Hannon-Fletcher, M., noScott, uJM Riboflavin wehlisa i-homocysteine kubantu abane-homozygous ye-MTHFR 677C-> T polymorphism. Ukusakazwa kuka-1-3-2006; 113: 74-80. Buka okungaqondakali.
  84. USiassi, F. noGhadirian, P. Riboflavin ukuntuleka kanye nomdlavuza wokuqopha: isifundo sokulawulwa kwamacala eCaspian Littoral yase-Iran. Ukuthola umdlavuza Ngaphambi kuka-2005; 29: 464-469. Buka okungaqondakali.
  85. USandor, P. S. no-Afra, J. Ukwelashwa kwe-Nonpharmacologic ye-migraine. I-Curr Pain Head Head Rep 2005; 9: 202-205. Buka okungaqondakali.
  86. UCiliberto, H., Ciliberto, M., Briend, A., Ashorn, P., Bier, D., noManary, M. Antioxidant supplementation yokuvikela i-kwashiorkor ezinganeni zaseMalawi: icala elilawulwa ngokungahleliwe, eliyimpumputhe, elilawulwa yi-placebo. BMJ 5-14-2005; 330: 1109. Buka okungaqondakali.
  87. Ukuxineka, J. J., Dowey, L., Ward, M., Pentieva, K., noMcNulty, H. B-vithamini, i-homocysteine ​​metabolism ne-CVD. I-Proc. Nutr Soc 2004; 63: 597-603. Buka okungaqondakali.
  88. Brosnan, J. T. Homocysteine ​​nesifo senhliziyo: ukuxhumana phakathi kokudla, ufuzo kanye nendlela yokuphila. ICan. J Appl.Physiol 2004; 29: 773-780. Buka okungaqondakali.
  89. UMacdonald, H. M., McGuigan, F. E., Fraser, W. D., New, S. A., Ralston, S. H., noReid, D. M. Methylenetetrahydrofolate reductase polymorphism ihlangana nokudla kwe-riboflavin ukuthonya ukuminyana kwamathambo. Ithambo 2004; 35: 957-964. Buka okungaqondakali.
  90. UBwibo, N. O. noNeumann, C. G. Isidingo sokudla komthombo wezilwane ngabantwana baseKenya. J Umsoco 2003; 133 (11 Isigaba 2): 3936S-3940S. Buka okungaqondakali.
  91. UPark, YH, de Groot, L. C., novan Staveren, W. A. ​​Ukudla kanye ne-anthropometry yabantu asebekhulile baseKorea: ukubukezwa kwezincwadi. I-Asia Pac. J Umtholampilo Wezempilo 2003; 12: 234-242. Buka okungaqondakali.
  92. UDyer, A. R., Elliott, P., Stamler, J., Chan, Q., Ueshima, H., noZhou, B. F. Ukudla kwabantu ababhemayo abesilisa nabesifazane, ababhemayo, futhi abangakaze babheme: isifundo se-INTERMAP. J Hum. Hypertens. 2003; 17: 641-654. Buka okungaqondakali.
  93. Amandla, H. J. Riboflavin (uvithamini B-2) kanye nempilo. NginguJ J Clin Nutr 2003; 77: 1352-1360. Buka okungaqondakali.
  94. Hunt, I. F., Jacob, M., Ostegard, N. J., Masri, G., Clark, V. A., noCoulson, A. H. Umphumela wemfundo yokudla okunomsoco esimweni sokudla kwabesifazane abakhulelwe abahola kancane abahola eMexico. Ngingu-J J Nutriti 1976; 29: 675-684. Buka okungaqondakali.
  95. UWollensak, G., Spoerl, E., noSeiler, T. Riboflavin / i-ultraviolet-a-induced collagen crosslinking yokwelashwa kwe-keratoconus. Ngingu-J Ophthalmol. 2003; 135: 620-627. Buka okungaqondakali.
  96. INavarro, M. noWood, R. J. Plasma ishintsha kuma-micronutrients kulandela ukwengezwa kwe-multivitamin namaminerali kubantu abadala abaphilile. J Ngingu-Coll Nutriti 2003; 22: 124-132. Buka okungaqondakali.
  97. UMoat, S. J., Ashfield-Watt, P. A., Amandla, H. J., Newcombe, R. G., noMcDowell, I. F. Umphumela wesimo se-riboflavin kumthelela we-homocysteine ​​we-folate maqondana ne-genotype ye-MTHFR (C677T). Umtholampilo Chem 2003; 49: 295-302. Buka okungaqondakali.
  98. UWollensak, G., Sporl, E., noSeiler, T. [Ukwelashwa kwe-keratoconus ngokuxhumanisa i-collagen cross]. I-Ophthalmologe 2003; 100: 44-49. Buka okungaqondakali.
  99. U-Apeland, T., Mansoor, M. A., Pentieva, K., McNulty, H., Seljeflot, I., noStrandjord, R. E. Umphumela wamavithamini e-B ku-hyperhomocysteinemia ezigulini zemithi ye-antiepileptic. Isifo sokuwa 2002; 51: 237-247. Buka okungaqondakali.
  100. UHustad, S., McKinley, MC, McNulty, H., Schneede, J., Strain, JJ, Scott, JM, no-Ueland, u-PM Riboflavin, u-flavin mononucleotide, no-flavin adenine dinucleotide ku-plasma yabantu kanye nama-erythrocyte ekuqaleni kanye nangemva kokuphansi -dose riboflavin ukwengeza. Umtholampilo Chem 2002; 48: 1571-1577. Buka okungaqondakali.
  101. UMcNulty, H., McKinley, M. C., Wilson, B., McPartlin, J., Strain, J. J., Weir, D. G., noScott, J. M. Ukukhubazeka ukusebenza kwe-thermolabile methylenetetrahydrofolate reductase kuncike kwisimo se-riboflavin: imiphumela yezidingo ze-riboflavin. Ngingu-J J Nutriti 2002; 76: 436-441. Buka okungaqondakali.
  102. UYoon, HR, Hahn, SH, Ahn, YM, Jang, SH, Shin, YJ, Lee, EH, Ryu, KH, Eun, BL, Rinaldo, P., noYamaguchi, S. Isivivinyo sokwelashwa emacaleni amathathu okuqala ase-Asia ye-ethylmalonic encephalopathy: impendulo ku-riboflavin. J Ifa. I-Metab Dis 2001; 24: 870-873. Buka okungaqondakali.
  103. UDing, Z., Gao, F., noLin, P. [Umphumela wesikhathi eside wokwelapha iziguli ezinezilonda zangaphambi kwesifo]. UZhonghua Zhong. Liu Za Zhi 1999; 21: 275-277. Buka okungaqondakali.
  104. ULin, P., Chen, Z., Hou, J., Liu, T., noWang, J. [Chemoprevention womdlavuza wokucinana]. UZhongguo Yi Xue Ke Xue Yuan Xue Bao 1998; 20: 413-418. Buka okungaqondakali.
  105. Sanchez-Castillo, CP, Lara, J., Romero-Keith, J., Castorena, G., Villa, AR, Lopez, N., Pedraza, J., Medina, O., Rodriguez, C., Chavez-Peon , UMedina F., noJames, i-WP Nutrition kanye ne-cataract kubantu baseMexico abahola kancane: isipiliyoni ekamu le-Eye. I-Arch Latinoam Nutrut 2001; 51: 113-121. Buka okungaqondakali.
  106. Inhloko, K. A. Ukwelashwa kwemvelo kokuphazamiseka kwe-ocular, ingxenye yesibili: i-cataract ne-glaucoma. Okuhlukile.I-Med. 2001; 6: 141-166. Buka okungaqondakali.
  107. UMassiou, H. [Ukwelashwa nge-Prophylactic ye-migraine]. UMfu Neurol. (Paris) 2000; 156 Suppl 4: 4S79-4S86. Buka okungaqondakali.
  108. USilberstein, S. D., Goadsby, P. J., noLipton, R. B. Ukuphathwa kwe-migraine: indlela ye-algorithmic. I-Neurology 2000; 55 (9 Suppl 2): ​​S46-S52. Buka okungaqondakali.
  109. UHustad, S., Ueland, P. M., Vollset, S. E., Zhang, Y., Bjorke-Monsen, A. L., noSchneede, J. Riboflavin njengesinqumo se-plasma ngokuphelele i-homocysteine: ukuguqulwa komphumela yi-methylenetetrahydrofolate reductase C677T polymorphism. Umtholampilo Chem 2000; 46 (8 Pt 1): 1065-1071. Buka okungaqondakali.
  110. UTaylor, P. R., Li, B., Dawsey, S. M., Li, J. Y., Yang, C. S., Guo, W., noBlot, uW. J. Ukuvimbela umdlavuza we-esophageal: izilingo zokungenelela kokudla eLinxian, eChina. ILinxian Nutrition Intervention Trials Study Group.ICancer Res 4-1-1994; 54 (7 Suppl): 2029s-2031s. Buka okungaqondakali.
  111. Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S. M., noLi, B. Izilingo zeLinxian: amazinga okufa kwabantu ngeqembu lokungenelela kwamavithamini. Ngingu-J J Nutriti 1995; 62 (6 Suppl): 1424S-1426S. Buka okungaqondakali.
  112. Qu, CX, Kamangar, F., Fan, JH, Yu, B., Sun, XD, Taylor, PR, Chen, BE, Abnet, CC, Qiao, YL, Mark, SD, noDawsey, SM Chemoprevention yesibindi sokuqala umdlavuza: icala elingahleliwe, eliyimpumputhe kabili eLinxian, eChina. J Natl.Cancer Inst. 8-15-2007; 99: 1240-1247. Buka okungaqondakali.
  113. IBates, CJ, Evans, PH, Allison, G., Sonko, BJ, Hoare, S., Goodrich, S., kanye no-Aspray, T. Izinkomba zamakhemikhali kanye nokuhlolwa kokusebenza kwe-neuromuscular ezinganeni zesikole zasemakhaya zaseGambia ezinikezwe i-riboflavin, noma i-multivitamin plus iron , engeza. Br.J Nutr. 1994; 72: 601-610. Buka okungaqondakali.
  114. I-Charoenlarp, ​​P., Pholpothi, T., Chatpunyaporn, P., ne-Schelp, F. P. Umphumela we-riboflavin ekushintsheni kwe-hematologic ekwenziweni kwensimbi kwezingane zesikole. ENingizimu-mpumalanga ye-Asia J. Trrop. Medied Public Health 1980; 11: 97-103. Buka okungaqondakali.
  115. Amandla, H. J., Bates, C. J., Prentice, A. M., Lamb, W. H., Jepson, M., noBowman, H. Ukusebenza okuhambisanayo kwensimbi nensimbi ne-riboflavin ekulungiseni i-anaemia encane emadodeni nasezinganeni ezisemakhaya eGambia. I-Hum.Nutr.Clin.Nutr. 1983; 37: 413-425. Buka okungaqondakali.
  116. Bates, C. J., Powers, H. J., Lamb, W. H., Gelman, W., noWebb, E. Umphumela wamavithamini ayinsimbi kanye nensimbi kuma-indices e-malaria ezinganeni zasemakhaya zaseGambia. Ukudlulisa.R.Soc.Trop.Med.Hyg. 1987; 81: 286-291. Buka okungaqondakali.
  117. Kabat, G. C., Miller, A. B., Jain, M., noRohan, T. E. Ukudla ukudla kwamavithamini akhethiwe we-B maqondana nengozi yomdlavuza omkhulu kwabesifazane. Br. J. Cancer 9-2-2008; 99: 816-821. Buka okungaqondakali.
  118. UMcNulty, H., Pentieva, K., Hoey, L., noWard, M. Homocysteine, B-vithamini kanye ne-CVD. I-Proc. Nutr Soc. 2008; 67: 232-237. Buka okungaqondakali.
  119. Stott, DJ, MacIntosh, G., Lowe, GD, Rumley, A., McMahon, AD, Langhorne, P., Tait, RC, O'Reilly, DS, Spilg, EG, MacDonald, JB, MacFarlane, PW, kanye I-Westendorp, i-RG Isivivinyo esilawulwa ngokungahleliwe sokwehlisa ukwelashwa kwamavithamini e-homocysteine ​​ezigulini esezikhulile ezinesifo semithambo. NginguJ. J Clin.Nutr 2005; 82: 1320-1326. Buka okungaqondakali.
  120. UModi, S. noLowder, D. M. Imithi ye-migraine prophylaxis. Ngingu-Fam. Udokotela 1-1-2006; 73: 72-78. Buka okungaqondakali.
  121. I-Woolhouse, M. Migraine kanye nobunzima bekhanda - indlela yokwelapha ehambisanayo neyenye indlela. U-Aust Fam. Udokotela 2005; 34: 647-651. Buka okungaqondakali.
  122. U-Premkumar, V. G., Yuvaraj, S., Sathish, S., Shanthi, P., noSachdanandam, P. Amandla we-anti-angiogenic weCoenzymeQ10, riboflavin kanye ne-niacin ezigulini zomdlavuza webele ezelashwa i-tamoxifen therapy. IVascul. Ikhemisi. 2008; 48 (4-6): 191-201. Buka okungaqondakali.
  123. I-Tepper, S. J. Ukwelashwa okuhambisanayo nokunye okuhlukile kwekhanda lobuntwana. I-Curr Pain Head Head Rep. 2008; 12: 379-383. Buka okungaqondakali.
  124. Kamangar, F., Qiao, YL, Yu, B., Sun, XD, Abnet, CC, Fan, JH, Mark, SD, Zhao, P., Dawsey, SM, noTaylor, PR Lung cancer chemoprevention: a randomized, icala elimpumputhe kabili eLinxian, eChina. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 2006; 15: 1562-1564. Buka okungaqondakali.
  125. I-Sun-Edelstein, C. neMauskop, A. Ukudla kanye nezengezo ekuphathweni kwekhanda le-migraine. Umtholampilo J Pain 2009; 25: 446-452. Buka okungaqondakali.
  126. UShargel L, Mazel P. Umphumela wokushoda kwe-riboflavin ku-phenobarbital kanye ne-3-methylcholanthrene induction of microsomal drug-metabolizing enzyme of the rat. I-Biochem Pharmacol. Ngo-1973; 22: 2365-73. Buka okungaqondakali.
  127. I-Fairweather-Tait SJ, Amandla HJ, Minski MJ, et al. Ukushoda kweRiboflavin nokufakwa kwensimbi emadodeni amadala aseGambia. U-Ann Nutr Metab. 1992; 36: 34-40. Buka okungaqondakali.
  128. ULeeson LJ, Weidenheimer JF. Ukuzinza kwe-tetracycline ne-riboflavin. UJ Pharm Sci. 1969; 58: 355-7. Buka okungaqondakali.
  129. UPringsheim T, uDavenport W, uMackie G, et al. Umhlahlandlela weCanada Headache Society we-migraine prophylaxis. Ingabe uJ Neurol. Isayensi 2012; 39: S1-59. Buka okungaqondakali.
  130. IHolland S, iSilberstein SD, iFreitag F, et al. Ukuvuselelwa komhlahlandlela osuselwe ebufakazini: Ama-NSAID nezinye izindlela zokwelapha ezihambisanayo zokuvimbela i-episodic migraine kubantu abadala: Umbiko weKomidi Elincane LamaZinga Ekhwalithi le-American Academy of Neurology kanye ne-American Headache Society. I-Neurology 2012; 78: 1346-53. Buka okungaqondakali.
  131. UJacques PF, Taylor A, Moeller S, et al. Ukudla okunomsoco wesikhathi eside kanye noshintsho lweminyaka emi-5 kuma-opacities welensi yenuzi. I-Arch Ophthalmol 2005; 123: 517-26. Buka okungaqondakali.
  132. Maizels M, Blumenfeld A, Burchette R. Inhlanganisela ye-riboflavin, i-magnesium, ne-feverfew ye-migraine prophylaxis: isilingo esingahleliwe. Izinwele 2004; 44: 885-90. Buka okungaqondakali.
  133. UBoehnke C, Reuter U, Flach U, et al. Ukwelashwa kwe-riboflavin ephezulu kusebenza kahle ku-migraine prophylaxis: isifundo esivulekile esikhungweni sokunakekelwa kwezemfundo ephakeme. I-Eur J Neurol 2004; 11: 475-7. Buka okungaqondakali.
  134. USandor PS, uDi Clemente L, uCoppola G, et al. Ukusebenza kwe-coenzyme Q10 ku-migraine prophylaxis: Isivivinyo esilawulwa ngokungahleliwe. I-Neurology 2005; 64: 713-5. Buka okungaqondakali.
  135. UHernandez BY, McDuffie K, uWilkens LR, et al. Ukudla nezilonda zangaphambi kwesibeletho somlomo wesibeletho: ubufakazi bendima yokuvikela i-folate, i-riboflavin, i-thiamin, ne-vitamin B12. Ukulawulwa Kwezifo Zomdlavuza 2003; 14: 859-70. Buka okungaqondakali.
  136. ISkalka HW, iPrchal JT. Ukwelashwa kwe-cataract kanye ne-riboflavin. Am J Clin Nutr 1981; 34: 861-3 .. Buka okungaqondakali.
  137. UBell IR, u-Edman JS, uMorrow FD, et al. Ukuxhumana okufushane. I-Vitamin B1, B2, ne-B6 ukwengezelela ukwelashwa kwe-tricyclic antidepressant ekucindezelekeni kwe-geriatric ngokungasebenzi kahle kwengqondo. J Am Coll Nutriti 1992; 11: 159-63 .. Buka okungaqondakali.
  138. UNegri E, uFranceschi S, uBostiti C, et al. Ama-micronutrients akhethiwe kanye nomdlavuza womlomo nowepharyngeal. I-Int J Cancer 2000; 86: 122-7 .. Buka okungaqondakali.
  139. I-Vir SC, Uthando AH. I-Riboflavin nutriture yabasebenzisi bokukhulelwa ngomlomo. I-Int J Vitam Nutr Res 1979; 49: 286-90 .. Buka okungaqondakali.
  140. U-Hamajima S, u-Ono S, u-Hirano H, u-Obara K. Ukwenziwa kohlelo lwe-FAD synthetase kusibindi segundane ngokuphathwa kwe-phenobarbital. I-Int J Vit Nutr Res 1979; 49: 59-63 .. Buka okungaqondakali.
  141. U-Ohkawa H, u-Ohishi N, u-Yagi K. Hydroxylation wamaqembu ama-7 no-8-methyl e-riboflavin ngohlelo lokudluliswa kwe-electron microsomal yesibindi segundane. J Biol Chem 1983; 258: 5629-33 .. Buka okungaqondakali.
  142. UPinto J, uHuang YP, uPelliccione N, uRivlin RS. I-Adriamycin ivimbela ukuhlanganiswa kwe-flavin enhliziyweni: ukuhlobana okungenzeka kube ne-cardiotoxicity ye-anthracyclines (abstract). Umtholampilo Res 1983; 31; 467A.
  143. URaiczyk GB, uPinto J.Ukuvinjelwa kwe-flavin metabolism yi-adriamycin emisipha yamathambo. I-Biochem Pharmacol 1988; 37: 1741-4 .. Buka okungaqondakali.
  144. U-Ogura R, Ueta H, uHino Y, et al. Ukushoda kweRiboflavin kubangelwa ukwelashwa nge-adriamycin. J Nutr Sci Vitaminol 1991; 37: 473-7 .. Buka okungaqondakali.
  145. U-Lewis CM, uKing JC. Umphumela wezinto zokuvimbela inzalo ngomlomo ku-thiamin, riboflavin, kanye nesimo se-pantothenic acid kwabesifazane abasebasha. Am J Clin Nutr 1980; 33: 832-8 .. Buka okungaqondakali.
  146. URoe DA, uBogusz S, uSheu J, et al. Izici ezithinta izidingo ze-riboflavin zabasebenzisi bokukhulelwa bomlomo nabangewona abasebenzisi. Am J Clin Nutr 1982; 35: 495-501 .. Buka okungaqondakali.
  147. UNewman LJ, uLopez R, uCole HS, et al. Ukushoda kweRiboflavin kwabesifazane abathatha izinto zokuvimbela inzalo ngomlomo. Am J Clin Nutr 1978; 31: 247-9 .. Buka okungaqondakali.
  148. Briggs M. Oral contraceptives kanye novithamini Nutrition (incwadi). ILancet 1974; 1: 1234-5. Buka okungaqondakali.
  149. U-Ahmed F, i-Bamji MS, i-Iyengar L. Umphumela wezinto zokuvimbela inzalo ngomlomo esimweni sokudla okunamavithamini. Am J Clin Nutrth 1975; 28: 606-15 .. Buka okungaqondakali.
  150. UDutta P, Pinto J, Rivlin R. Imiphumela ye-Antimalarial yokushoda kwe-riboflavin. ILancet 1985; 2: 1040-3. Buka okungaqondakali.
  151. I-Raiczyk GB, i-Dutta P, i-Pinto J. Chlorpromazine ne-quinacrine ivimbela i-flavin adenine dinucleotide biosynthesis emisipha yamathambo. Isazi somzimba 1985; 28: 322.
  152. UPelliccione N, uPinto J, uHuang YP, uRivlin RS. Ukuthuthuka okusheshayo kokuntuleka kwe-riboflavin ngokwelashwa nge-chlorpromazine. I-Biochem Pharmacol 1983; 32: 2949-53 .. Buka okungaqondakali.
  153. UPinto J, uHuang YP, uPelliccione N, uRivlin RS. Ukuzwela kwenhliziyo emiphumeleni yokuvimbela i-chlorpromazine, imipramine, ne-amitriptyline lapho kwakhiwa ama-flavour. I-Biochem Pharmacol 1982; 31: 3495-9 .. Buka okungaqondakali.
  154. UPinto J, uHuang YP, uRivlin RS. Ukuvinjelwa kwe-riboflavin metabolism kwizicubu zamagundane yi-chlorpromazine, imipramine ne-amitriptyline. J Clin Invest 1981; 67: 1500-6. Buka okungaqondakali.
  155. UJusko WJ, Levy G, Yaffe SJ, Gorodischer R. Umphumela we-probenecid ekususweni kwe-renal ye-riboflavin kumuntu. J Pharm Sci 1970; 59: 473-7. Buka okungaqondakali.
  156. UJusko WJ, Levy G. Umphumela we-probenecid ekumungeni kwe-riboflavin nokukhipha kumuntu. UJ Pharm Sci 1967; 56: 1145-9. Buka okungaqondakali.
  157. UYanagawa N, Shih RN, Jo OD, Said HM. Ukuthuthwa kweRiboflavin ngamatubules asezintanjeni asebenze ngokweqile afuthwe. NginguJ J Physiol Cell Physiol 2000; 279: C1782-6 .. Buka okungaqondakali.
  158. UDalton SD, uRahimi AR. Indima eqhamukayo ye-riboflavin ekwelapheni i-nucleoside analogue-indened type B lactic acidosis. I-AIDS Patient Care STDS 2001; 15: 611-4 .. Buka okungabonakali.
  159. Roe DA, Kalkwarf H, Stevens J. Umphumela wezithasiselo ze-fiber ekuthathweni okubonakalayo kwemithamo yemithi ye-riboflavin. J Am Diet Assoc 1988; 88: 211-3 .. Buka okungaqondakali.
  160. I-Pinto J, i-Raiczyk GB, i-Huang YP, i-Rivlin RS. Izindlela ezintsha zokuvimbela imiphumela emibi yokwelashwa ngamakhemikhali ngokudla. Umdlavuza 1986; 58: 1911-4 .. Buka okungaqondakali.
  161. UMcCormick DB. Riboflavin. Ku: Shils ME, Olson JA, Shike M, Ross AC, eds. Ukondleka Kwamanje Ezempilo Nezifo. Umhlaka 9. IBaltimore, MD: Williams & Wilkins, 1999. kk. 391-9.
  162. UFishman SM, uChristian P, West KP. Indima yamavithamini ekuvimbeleni nasekulawuleni i-anemia. I-Public Health Nutr 2000; 3: 125-50 .. Buka okungaqondakali.
  163. UTyrer LB. Ukudla okunomsoco kanye nephilisi. J Reprod Med 1984; 29: 547-50 .. Buka okungaqondakali.
  164. UMooij PN, uThomas CM, iDisburg WH, u-Eskes TK. Ukwengezwa kweMultivitamin kubasebenzisi bokukhulelwa bomlomo. Ukuvimbela Ukukhulelwa 1991; 44: 277-88. Buka okungaqondakali.
  165. USazawal S, uMnyama RE, uMenon VP, et al. Ukwengezwa kwe-Zinc ezinganeni ezizalwe zincane ngeminyaka yokukhulelwa kunciphisa ukufa: isilingo esizayo, esingahleliwe, esilawulwayo. Izifo zezingane 2001; 108: 1280-6. Buka okungaqondakali.
  166. UCumming RG, Mitchell P, Smith W. Ukudla kanye ne-cataract: iBlue Mountains Eye Study. I-Ophthalmology 2000; 10: 450-6. Buka okungaqondakali.
  167. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezikhombo Zezokudla ku-Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, neCholine. IWashington, DC: National Academy Press, 2000. Itholakala ku: http://books.nap.edu/books/0309065542/html/.
  168. U-Kulkarni PM, iSchuman PC, uMerlino NS, uKinzie JL. I-Lactic acidosis ne-hepatic steatosis ezigulini ezinesifo se-HIV eziphathwe ngama-nucleoside analogues. Iphrojekthi ye-Natl AIDS Advocacy Project. Iviki Lesifo Sezifo Isibindi Conf, San Diego, CA. 2000; Meyi 21-4: Rep11.
  169. Ikhodi ye-elekthronikhi yemithethonqubo kahulumeni. Isihloko 21. Ingxenye 182 - Izinto Ngokuvamile Zaziwa Njengokuphepha. Kutholakala ku: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  170. ISperduto RD, i-Hu TS, iMilton RC, et al. Izifundo ze-Linxian cataract. Izilingo ezimbili zokungenelela kokudla. I-Arch Ophthalmol 1993; 111: 1246-53. Buka okungaqondakali.
  171. UWang GQ, uDawsey SM, uLi JY, et al. Imiphumela yokwengeza ivithamini / amaminerali ekusakazekeni kwe-histological dysplasia nomdlavuza wokuqala we-esophagus nesisu: imiphumela evela ku-General Population Trial eLinxian, eChina. I-Cancer Epidemiol Biomarkers Prev 1994; 3: 161-6. Buka okungaqondakali.
  172. INimmo WS. Izidakamizwa, izifo, nokuguqulwa kokuchithwa kwesisu. Umtholampilo Pharmacokinet 1967; 1: 189-203. Buka okungaqondakali.
  173. ISanpitak N, Chayutimonkul L. Izindlela zokuvimbela inzalo zomlomo kanye nomsoco we-riboflavin. ILancet 1974; 1: 836-7. Buka okungaqondakali.
  174. IHill MJ. Izimbali zamathumbu kanye ne-vitamin endogenous synthesis. I-Eur J Cancer Prev 1997; 6: S43-5. Buka okungaqondakali.
  175. I-Yates AA, iSchlicker SA, iSuitor CW. Ukufakwa kwereferensi yokudla: Isisekelo esisha sezincomo ze-calcium nezakhi ezihlobene, amavithamini B, ne-choline. J Am Ukudla Assoc 1998; 98: 699-706. Buka okungaqondakali.
  176. UKastrup EK. Amaqiniso Wezidakamizwa Nokuqhathanisa. 1998 u-ed. ISt. Louis, MO: Amaqiniso nokuqhathanisa, ngo-1998.
  177. UMark SD, uWang W, uFraumeni JF Jr, et al. Ingabe izithasiselo zokudla okunomsoco zehlisa ingozi yokushaywa unhlangothi noma umfutho wegazi ophakeme? I-Epidemiology 1998; 9: 9-15. Buka okungaqondakali.
  178. IBlot WJ, Li JY, Taylor PR. Izilingo zokungenelela kokudla okunomsoco eLinxian, eChina: ukwengezelelwa ngenhlanganisela ethile yamavithamini / amaminerali, izehlakalo zomdlavuza, kanye nokufa okuqondene nezifo kubantu abaningi. UJ Natl Cancer Inst 1993; 85: 1483-92. Buka okungaqondakali.
  179. UFouty B, Frerman F, Reves R. Riboflavin ukwelapha i-lactic acidosis eyenziwe nge-nucleoside analogue. ILancet 1998; 352: 291-2. Buka okungaqondakali.
  180. USchoenen J, uJacquy J, uLenaerts M. Ukuphumelela kwe-high-dose riboflavin ku-migraine prophylaxis. Isilingo esilawulwa ngokungahleliwe. I-Neurology 1998; 50: 466-70. Buka okungaqondakali.
  181. I-Schoenen J, i-Lenaerts M, i-Bastings E. I-high-dose riboflavin njengokwelashwa kwe-prophylactic ye-migraine: imiphumela yocwaningo lomshayeli ovulekile. ICephalalgia 1994; 14: 328-9. Buka okungaqondakali.
  182. I-Sandor PS, i-Afra J, i-Ambrosini A, i-Schoenen J. Ukwelashwa kwe-Prophylactic ye-migraine ne-beta-blockers kanye ne-riboflavin: imiphumela ehlukile ekuthembekeni okukhulu kwamandla we-cortical. Izinwele 2000; 40: 30-5. Buka okungaqondakali.
  183. UKunsman GW, uLevine B, uSmith ML. Ukungenelela kuka-Vitamin B2 ngezilingo zokusebenzisa kabi izidakamizwa ze-TDx. UJ Forensic Sci 1998; 43: 1225-7. Buka okungaqondakali.
  184. IGupta SK, Gupta RC, Seth AK, Gupta A.Ukuguqulwa kwe-fluorosis ezinganeni. I-Acta Paediatr Jpn 1996; 38: 513-9. Buka okungaqondakali.
  185. UHardman JG, uLimbird LL, uMolinoff PB, ama-eds. UGoodman noGillman’s The Pharmacological Basis of Therapeutics, umhla ka-9. ENew York, NY: McGraw-Hill, 1996.
  186. I-DS encane. Imiphumela Yezidakamizwa Ekuvivinyweni Kwelabhoratri Yomtholampilo 4th ed. IWashington: I-AACC Press, 1995.
  187. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.
  188. UFoster S, uTyler VE. Amakhambi Athembekile KaTyler: Umhlahlandlela Oqondakalayo Wokusetshenziswa Kwamakhambi Namakhambi Ahlobene. 3rd ed., Binghamton, NY: I-Haworth Herbal Press, ngo-1993.
  189. INewall CA, Anderson LA, uPhilpson JD. Herbal Medicine: Umhlahlandlela Wongoti Bezempilo. ILondon, e-UK: I-Pharmaceutical Press, ngo-1996.
  190. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
  191. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
  192. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Kugcine ukubuyekezwa - 08/19/2020

Ukukhethwa Kwesiza

I-COPD nezinye izinkinga zempilo
Umuthi

I-COPD nezinye izinkinga zempilo

Uma une ifo e ingapheliyo e-pulmonary di ea e (COPD), kungenzeka ukuthi unezinye izinkinga zezempilo, futhi. Lokhu kubizwa ngokuthi ama-comorbiditie . Abantu abane-COPD bavame ukuba nezinkinga zempilo...
Ukuqonda Isifundo Samagama Ezokwelapha
Umuthi

Ukuqonda Isifundo Samagama Ezokwelapha

Uthini udokotela?Ngabe uke uzizwe engathi wena nodokotela wakho anikhulumi ulimi olufanayo? Kwe inye i ikhathi ngi ho namagama ocabanga ukuthi uyawaqonda angaba nencazelo ehlukile kudokotela wakho.Ng...